Cargando…

Mapping the EORTC QLQ-C30 onto the EQ-5D-5L index for patients with paroxysmal nocturnal hemoglobinuria in France

AIMS: To map patient-level data collected on the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC) QLQ-C30 to EQ-5D-5L data for estimating health-state utilities in patients with paroxysmal nocturnal hemoglobinuria (PNH). MATERIALS & METHODS: Europe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wojciechowski, Piotr, Wdowiak, Marlena, Hakimi, Zalmai, Wilson, Koo, Fishman, Jesse, Nazir, Jameel, Toumi, Mondher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Becaris Publishing Ltd 2023
Materias:	Methodology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402747/ https://www.ncbi.nlm.nih.gov/pubmed/37052120 http://dx.doi.org/10.57264/cer-2022-0178

Ejemplares similares

Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients
por: Kim, Seon Ha, et al.
Publicado: (2012)

No impact of Asian ethnicity on EORTC QLQ-C30 scores: Group differences and differential item functioning in paroxysmal nocturnal hemoglobinuria
por: Schwartz, Carolyn E., et al.
Publicado: (2021)

Mapping EORTC-QLQ-C30 onto EQ-5D-5L Index in Indonesian Cancer Patients
por: Perwitasari, Dyah Aryani, et al.
Publicado: (2023)

Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer
por: Hagiwara, Yasuhiro, et al.
Publicado: (2020)

Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesothelioma
por: Arnold, David T, et al.
Publicado: (2015)

Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma
por: Proskorovsky, Irina, et al.
Publicado: (2014)

Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after
por: Miret, Carme, et al.
Publicado: (2023)

Changes in hemoglobin and clinical outcomes drive improvements in fatigue, quality of life, and physical function in patients with paroxysmal nocturnal hemoglobinuria: post hoc analyses from the phase III PEGASUS study
por: Cella, David, et al.
Publicado: (2022)

Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer
por: Gray, Laura A., et al.
Publicado: (2021)

Necrotizing Fasciitis in Paroxysmal Nocturnal Hemoglobinuria
por: Patir, Pusem, et al.
Publicado: (2015)

Evolutionary dynamics of paroxysmal nocturnal hemoglobinuria
por: Mon Père, Nathaniel, et al.
Publicado: (2018)

Renal Manifestations in Paroxysmal Nocturnal Hemoglobinuria
por: Ram, R., et al.
Publicado: (2017)

Insights Into the Emergence of Paroxysmal Nocturnal Hemoglobinuria
por: Colden, Melissa A., et al.
Publicado: (2022)

Management of paroxysmal nocturnal hemoglobinuria (PNH)
por: Luzzatto, Lucio
Publicado: (2022)

Paroxysmal Nocturnal Hemoglobinuria: Biology and Treatment
por: Bravo-Perez, Carlos, et al.
Publicado: (2023)

Early Mortality in Paroxysmal Nocturnal Hemoglobinuria
por: Sørensen, Anne Lykke, et al.
Publicado: (2023)

Pregnancy in Classical Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia–Paroxysmal Nocturnal Hemoglobinuria: A High-Risk Constellation
por: Alashkar, Ferras, et al.
Publicado: (2020)

Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model
por: Franken, Mira D., et al.
Publicado: (2020)

Correction to: Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer
por: Gray, Laura A., et al.
Publicado: (2022)

Hemoglobinuria Misidentified as Hematuria: Review of Discolored Urine and Paroxysmal Nocturnal Hemoglobinuria
por: Veerreddy, Prashant
Publicado: (2013)

A Case of Paroxysmal Cold Hemoglobinuria Possessing Moderate Paroxysmal Nocturnal Hemoglobinuria-Type Erythrocytes
por: Sugimoto, Takeshi, et al.
Publicado: (2021)

The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab
por: Kelly, Richard, et al.
Publicado: (2009)

Moyamoya Syndrome Caused by Paroxysmal Nocturnal Hemoglobinuria
por: Cheng, Zhi-Juan, et al.
Publicado: (2018)

Paroxysmal Nocturnal Hemoglobinuria in the Differential Diagnosis of Thrombocytopenia
por: Gediz, Fusun, et al.
Publicado: (2017)

The Role of T Lymphocytes in the Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria
por: Li, Chenyuan, et al.
Publicado: (2021)

Safety and efficacy of pegcetacoplan in paroxysmal nocturnal hemoglobinuria
por: Wong, Raymond S.M.
Publicado: (2022)

Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria
por: Stern, Robert M., et al.
Publicado: (2019)

Mapping the EORTC QLQ-C30 and QLQ-H&N35 to the EQ-5D for head and neck cancer: Can disease-specific utilities be obtained?
por: Beck, Ann-Jean C. C., et al.
Publicado: (2019)

Comparison of High Sensitivity and Conventional Flow Cytometry for Diagnosing Overt Paroxysmal Nocturnal Hemoglobinuria and Detecting Minor Paroxysmal Nocturnal Hemoglobinuria Clones
por: Park, Sang Hyuk, et al.
Publicado: (2019)

Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients
por: Khan, Iftekhar, et al.
Publicado: (2016)

The cost–effectiveness of pegcetacoplan in complement treatment-naïve adults with paroxysmal nocturnal hemoglobinuria in the USA
por: Fishman, Jesse, et al.
Publicado: (2023)

Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder
por: Desroziers, Katia, et al.
Publicado: (2013)

Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria
por: Nishimura, Jun-ichi, et al.
Publicado: (2021)

Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria
Publicado: (1987)

Recent advances in the pathogenesis and treatment of paroxysmal nocturnal hemoglobinuria
por: Luzzatto, Lucio
Publicado: (2016)

Autosplenectomy in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)
por: Burns, Ethan, et al.
Publicado: (2019)

Paroxysmal Nocturnal Hemoglobinuria: Diagnostic Challenges in Pediatric Patient
por: Krishnaprasadh, Dharshana, et al.
Publicado: (2019)

Diagnostic and Treatment Challenges of Paroxysmal Nocturnal Hemoglobinuria in Uganda
por: Lumori, Boniface Amanee Elias, et al.
Publicado: (2019)

Paroxysmal Nocturnal Hemoglobinuria: An Underestimated Cause of Pediatric Thromboembolism
por: Griesser, Christina, et al.
Publicado: (2020)

COVID‐19 infection presenting as paroxysmal nocturnal hemoglobinuria
por: Hines, Adam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e5eins3dg6v8tru1kld4pvapvs